Adolescents (12–17 years)

Eligibility

Individuals of all ages with a professional diagnosis of autism and their family members may participate.

Purpose

SPARK: Simons Foundation Powering Autism Research and Knowledge is a landmark national autism research study designed to speed up research and advance our understanding of autism to help improve lives. SPARK will collect unique information from thousands of individuals affected by autism to give researchers the information they need to improve treatment and achieve scientific advances as rapidity as possible. More participants in SPARK means more good data for research.

Involvement

Participation in SPARK can be done entirely at home – registration can be completed online and the DNA sample can be provided using a saliva collection kit mailed to the home. There is no cost to participate.

Benefits

Upon completion of the registration process, the individual with autism will receive a $50 gift card.

Contact

Daniella Lucio: dlucio@mednet.ucla.edu

For more information visit https://sparkforautism.org/?code=ucla

Get Study Flyer


Learn more about SPARK for Autism!

Eligibility:
Individuals with Angelman Syndrome (ages 1-12 or 18 and over), Typically Developing Children (ages 1-12)

Purpose:
This is a prospective, longitudinal, non-drug study at one or more clinical centers in individuals with AS and in volunteers (typically developing controls) with the aim of characterizing sleep features, electrophysiological abnormalities, and neurodevelopment in individuals with AS over a range of ages and genotypes.

Involvement:
Each participant will be evaluated at 2 clinic visits (at the start and the end of the study), at up to 3 home visits for EEG and overnight polysomnography (PSG) (up to 8 weeks after Clinic Visit 1, 3 months, after Home Visit 1, and 6 weeks or less before Clinic Visit 2), and with digital and report measures for 12 months at home. Study assessments will comprise various questionnaires and assessments to be completed by clinical evaluators, participants, and/or their parents/caregivers including exploratory remote patient monitoring.

Benefits:
The outcome of this study will help to improve the tests and scales used in the evaluation of Angelman in the future. You will also be compensated $263 for each visit to UCLA and $132 for each home visit that you complete. Additionally, all study-related assessments will be provided at no cost and you will be reimbursed for all travel expenses.

Contact:
Careese Stephens (cmstephens@mednet.ucla.edu) at 310-206-7404 or Logan Shurtz (lshurtz@mednet.ucla.edu) at 310-825-0180.

Click here to view flyer.

Eligibility

You are eligible to participate if you:

  • Are between 3-17 years old
  • Currently taking Risperidone or Aripiprazole
  • Parent or designated support person available

Purpose

The purpose of this 26-month (2 per year to visits to UCLA and monthly contacts) study is to examine long-term effects on weight, while taking Risperidone or Aripiprazole.

Involvement

  • In-person visits every 6 months include questionnaires about overall health, physical exam, vital signs, bloodwork
  • Brief monthly contacts for medication and health status updates

Benefits

Participants will receive reimbursement up to $250 ($50 per completed scheduled clinic visit)

Contact

autismresearch@ucla.edu
310-267-4798

Get Study Flyer

Eligibility

  • You have one or more children the ages of 3 years and older with symptoms of autism.
  • Families must be of African American descent

Purpose

To help researchers understand autism spectrum disorders in African American families.

Involvement

  • One screening phone call.
  • One in-person visit to our clinic or community site for up to 6 hours.
  • Observations of children’s behavior.
  • Questionnaires and interviews for parents about themselves and their children’s development.

Benefits

  • Participants will be paid $250.
  • Participants will receive a written feedback report summarizing the psychological test findings on their child(ren) with autism.

Contact

Erin Graham at (310) 794-4090 or at EGraham@mednet.ucla.edu

Get Study Flyer

Eligibility

  • Child between the ages of 7-17
  • Child with finalized adoption from DCFS
  • Child with typical development
  • Child with autism spectrum diagnosis

Purpose

  • To investigate the neural and behavioral mechanisms of sensory sensitivity.
  • To better understand how different groups of children interact with their sensory environments through neuroimaging and behavioral assessment.

Involvement

  • One brief phone call to complete a phone screener to determine eligibility
  • One mock scan visit (1-2 hrs) - participant paid $25
  • One scan/behavioral assessment visit (3-4 hrs) - participant paid $85

Benefits

  • Participant paid up to a total of $110
  • Participant will be sent a picture of their brain
  • Participant can choose to receive a written report of their sensory profile

Contact

Typical Development Flyer

ASD Flyer

Finalized Adoption Flyer

Eligibility:
Individuals who are:

  • Between 13-30 years
  • Have an autism spectrum disorder (ASD)

Purpose

The purpose of this 16-week study is to examine the combined effects of medication (L-DOPA or placebo) plus a specialized behavioral intervention aimed towards increasing social skills.

Involvement:
Participants will receive:

  • UCLA PEERS (social skills training, 1 session/week for 16 weeks). Participants must first enroll in UCLA PEERS prior to joining this research study.
  • Comprehensive diagnostic and cognitive evaluation
  • Neurological testing
  • L-DOPA or placebo (inactive medication)
  • Questionnaire, interviews, psychological and laboratory testing

Benefits

  • Up to $550 if all visits are completed
  • Specialized behavioral intervention aimed towards increasing social skills

Contact

Study coordinator: 310-267-4798
PEERS: 310-267-3377

Get Study Flyer

Eligibility

  • Children between the ages of 2-16
  • Individuals with an ASD diagnosis who are currently receiving services
  • Can speak in either phrase speech (2 words with a verb) or are verbally fluent

Purpose

The purpose of the BOSCC is to provide a standardized and efficient method of measuring change in social and communicative behaviors in people with neurodevelopmental disorders over a relatively short period of time (minimum 8-12 weeks). This study aims to assess the BOSCC’s sensitivity for children who can speak in simple sentences (2 word phrases containing a verb) or who communicate in complex sentences.

Involvement

This study involves two visits to UCLA, about 8-12 weeks apart, in which we conduct the BOSCC assessment (12-minute free play assessment with a standard set of toys).

Benefits

Families will receive $25 for each visit to UCLA, totaling $50 for both visits.

Contact

Chrissie Toolan, PhD: ctoolan@mednet.ucla.edu

Get Study Flyer

Eligibility

  • Children between the ages of 4-17
  • Must be diagnosed with a Neurodevelopmental Disorder

Purpose

The purpose of this study is to examine the effects of dance classes on motor skills and behavior.

Involvement

Participants will participate in FREE weekly dance classes (held via Zoom). Kids are paired 1-to-1 with a teacher who will modify the group classes to meet their unique needs and ability level.

Benefits

Participants will receive $100 upon completion of the study, as well as a unique opportunity to make friends and stay active from home!

Contact

Text “MORE INFO” to 303-718-6434
ucla.cart.dance@gmail.com

Get Study Flyer

Eligibility

  • Children between the ages of 8 and 15
  • Children with typical development
  • Children with autism spectrum diagnosis

Purpose

To examine how brain, behavioral, and physiological responses to sensory stimuli develop over time in children with autism spectrum disorder compared to typically developing children.

Involvement

  • One brief phone call to complete a phone screener to determine eligibility
  • One mock scan visit (1-2 hours)
  • Two scan/behavioral assessment visits (3-4 hours) over the course of two years
  • Questionnaires at each time point

Benefits

Participants will receive:

  • Up to $270 ($25 for the mock scan, $110 at each time point, a bonus $25 for the follow-up visit)
  • A picture of their brain
  • An optional research report on their sensory processing

Contact

Get Study Flyer

Eligibility
Children and adolescents between the ages of 6-17 years with autism spectrum disorder (ASD).

Purpose
The purpose of this study is to determine if cannabidiol oral solution (CBD) helps to improve symptoms associated with ASD, including behavior, emotion, cognition, and social skills.

Involvement
After a thorough screening visit to determine eligibility, if you and your child decide to join the study, your child's participation include the following periods:

  • Screening period (up to 2 weeks),
  • Study Treatment period (13 weeks) - You and your child will have 5 clinic visits (3 of which may be done at the study center or at your home via a video call) and 3 telephone calls.
  • Follow-up period (2 weeks)
The length of you and your child's participation in the study will be about 17 weeks (4 months).

Benefits
Hopefully, the study medication will help your child's symptoms and overall well-being, but that is not guaranteed. You will also be paid $50 per in-person visit, for a possible total of $400.

Contact
For more information, please contact: Jenny Cowen, PhD at jcowen@mednet.ucla.edu

Study PI: Dr. James McCracken